These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 17308143)

  • 1. Indices of low-grade inflammation in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Paterakis T; Kandarakis HA
    Ann N Y Acad Sci; 2006 Dec; 1092():175-86. PubMed ID: 17308143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indices of low-grade chronic inflammation in polycystic ovary syndrome and the beneficial effect of metformin.
    Diamanti-Kandarakis E; Paterakis T; Alexandraki K; Piperi C; Aessopos A; Katsikis I; Katsilambros N; Kreatsas G; Panidis D
    Hum Reprod; 2006 Jun; 21(6):1426-31. PubMed ID: 16497699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.
    Benson S; Janssen OE; Hahn S; Tan S; Dietz T; Mann K; Pleger K; Schedlowski M; Arck PC; Elsenbruch S
    Brain Behav Immun; 2008 Feb; 22(2):177-84. PubMed ID: 17716857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial response of ghrelin and PYY and indices of low-grade chronic inflammation in lean young women with polycystic ovary syndrome.
    Zwirska-Korczala K; Sodowski K; Konturek SJ; Kuka D; Kukla M; Brzozowski T; Cnota W; Woźniak-Grygiel E; Jaworek J; Bułdak R; Rybus-Kalinowska B; Fryczowski M
    J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():161-78. PubMed ID: 18812636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic inflammation and elevated homocysteine levels are associated with increased body mass index in women with polycystic ovary syndrome.
    Guzelmeric K; Alkan N; Pirimoglu M; Unal O; Turan C
    Gynecol Endocrinol; 2007 Sep; 23(9):505-10. PubMed ID: 17852421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.
    Ruan X; Dai Y
    Med Princ Pract; 2009; 18(2):118-22. PubMed ID: 19204430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular disease risk factors in polycystic ovary syndrome.
    Dokras A
    Semin Reprod Med; 2008 Jan; 26(1):39-44. PubMed ID: 18181081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-grade chronic inflammation is not accompanied by structural arterial injury in polycystic ovary syndrome.
    Costa LO; dos Santos MP; Oliveira M; Viana A
    Diabetes Res Clin Pract; 2008 Aug; 81(2):179-83. PubMed ID: 18499295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased serum neopterin levels in women with polycystic ovary syndrome.
    Barutcuoglu B; Bozdemir AE; Dereli D; Parildar Z; Mutaf MI; Ozmen D; Bayindir O
    Ann Clin Lab Sci; 2006; 36(3):267-72. PubMed ID: 16951267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory markers in relation to insulin resistance and the metabolic syndrome.
    Ingelsson E; Hulthe J; Lind L
    Eur J Clin Invest; 2008 Jul; 38(7):502-9. PubMed ID: 18489581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein levels are unaffected by metformin during pretreatment and an IVF cycle in women with polycystic ovary syndrome.
    Kjøtrød SB; Romundstad P; von Düring V; Sunde A; Carlsen SM
    Fertil Steril; 2008 Mar; 89(3):635-41. PubMed ID: 17548076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The adiponectin-to-leptin ratio in women with polycystic ovary syndrome: relation to insulin resistance and proinflammatory markers.
    Xita N; Papassotiriou I; Georgiou I; Vounatsou M; Margeli A; Tsatsoulis A
    Metabolism; 2007 Jun; 56(6):766-71. PubMed ID: 17512308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndrome.
    Chen MJ; Chen HF; Chen SU; Ho HN; Yang YS; Yang WS
    Fertil Steril; 2009 Dec; 92(6):2041-4. PubMed ID: 19591997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of metabolic syndrome and CRP on vascular phenotype in type 2 diabetes mellitus.
    Alizadeh Dehnavi R; Beishuizen ED; van de Ree MA; Le Cessie S; Huisman MV; Kluft C; Princen HM; Tamsma JT
    Eur J Intern Med; 2008 Mar; 19(2):115-21. PubMed ID: 18249307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome and chronic inflammation: pharmacotherapeutic implications.
    Sirmans SM; Weidman-Evans E; Everton V; Thompson D
    Ann Pharmacother; 2012 Mar; 46(3):403-18. PubMed ID: 22388330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of low-grade inflammation in the polycystic ovary syndrome.
    Repaci A; Gambineri A; Pasquali R
    Mol Cell Endocrinol; 2011 Mar; 335(1):30-41. PubMed ID: 20708064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS).
    Giallauria F; Palomba S; Maresca L; Vuolo L; Tafuri D; Lombardi G; Colao A; Vigorito C; Francesco O
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):792-8. PubMed ID: 18505468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers of outcome from cardiovascular disease.
    Khuseyinova N; Koenig W
    Curr Opin Crit Care; 2006 Oct; 12(5):412-9. PubMed ID: 16943718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.